Royalty Pharma (RPRX) is a very interesting and successful public offering, with shares having seen spectacular returns on their first few days of trading. The reason for the move higher is easily understood - an interesting business model which is very profitable and benefits from growing revenues.
I like the business. Although the significant move higher has killed the appeal for now, the business is interesting enough to keep a watch going forward.
An Interesting Biotech Play
Royalty Pharma has a mission to accelerate innovation in life sciences through collaboration with innovators in